7/25/2019 Seminar Copd

1/16

CHRONIC OBSTRUCTIVE

PULMONARY DISEASE(COPD)

7/25/2019 Seminar Copd

2/16

Definition of COPD

a common preventable and treatable disease, characterized by persistent airflow limitation

that is usually progressive and associated with an enhachronic inflammatory response

in the airways and the lung to noxious particles or gase

7/25/2019 Seminar Copd

3/16

Types of COPD "#$%&''( )*$ +,-.$ /0*1 2,*1 *().3 4&4.'( .0*1.4 ,5.6

7-)1($.-&

8

9.:5.; &$ &25,4-&'3).4-&5.5* .5'&4

7/25/2019 Seminar Copd

4/16

Emphysema and Chronic Bronchitis

7/25/2019 Seminar Copd

5/16

Pathophysiology

!"#$%&'( *#+'&&',$%-%./0$#/. $1 ,2. (3#4/ 53. ,$,$6*7 4'/./8

9./0$#/. $773%/ *# ,2.'*%:'-/ ;0'%.#72-&' ,5

G-&'' &04/&( ;0$.&$.8

E04/&( '0-0*&>,5

8

E04/&( :24,$0$3 '%-05&')'%+ 4.

7/25/2019 Seminar Copd

7/16

Risk factors for COPD

1.

from heating and cooking wit?0,5=4,- 1.&>5< &5;

+,,C05< /0*1 20,-&$$05 ),,4'( D.5>'&*.;

;/.''05,5"&04 ),''%>,56

E')1&NO E5>*4()$05;.:+0.5+( "+6

E$*1-& P 24,5+10&'1().44.$),5$0D.5.$$

Q.$)04&*,4( 05=.+>,5

7/25/2019 Seminar Copd

8/16

Clinical features

G(-)*,-$

8

R0$*,4( ,= 1.&D( $-,C05,5 *.$*$

N@( %$05< $)04,-.*4( X %$.; *, &$$.$$ *1. $.D.40*( ,= &04

,2$*4%+>,5

9,5. 2( -.&$%405< *1. U7YO "?KI96

Z,4-&' D&'%. X Y&4( ;.).5; ,5 $.S &5; &

7/25/2019 Seminar Copd

10/16

7/25/2019 Seminar Copd

11/16

U@?

N R2 ` I?Y -&( 2. 10

7/25/2019 Seminar Copd

12/16

7/25/2019 Seminar Copd

13/16

7?a

NE$$.$$ +&4;0&+ $*&*%$ 0= *1.4. &4. =.&*%4.$ ,= +,4 )%'-,

E@a &5&'($0$

N-.&$%4. ,S(

7/25/2019 Seminar Copd

14/16

G)%*%- +%'*%4.

NB, 0;.5>=( ,4

7/25/2019 Seminar Copd

15/16

L&5&

7/25/2019 Seminar Copd

16/16

?,-)'0+&>,5$

Q.$)04&*,4( =&0'%4.

?,4 )%'-,5&'.3 0^. 1.&4* ;0$.&$. $.+,5;&4( *, ;0$.&$.'%5,5

?.$$&>,5 ,= $-,C05,5

20,>+$ ")4.D.5* &+%*. .S&+.42&>,5$ ,= +,);6